Pharma 5.0

Designing tomorrow’s medicines with generative AI and quantum computing

Published: 13-Jun-2025

As the scale of biological complexity increases, so too must the tools we use to compute it. Pushing beyond the capabilities of classical technology into the realms of generative AI and quantum science, researchers are turning to more advanced techniques to keep up

You need to be a subscriber to read this article.
Click here to find out more.

Designing proteins and antibodies that can bind precisely to disease-associated targets is a cornerstone of therapeutics.

Specifically engineered antibodies and therapeutic proteins selectively bind to molecular targets associated with diseases, resulting in treatments that are both more effective and have fewer side-effects compared with traditional therapies.1 

Murat Tunaboylu, founder and CEO at Antiverse, reports. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like